Ticker Scorecard - BTAI Basics Company: BioXcel Therapeutics, Inc. IPO Date: March 5, 2018 Sector: Healthcare Industry: Biotech Market Cap: $6.61M Activated in VL: True Average Daily Range Avg Daily Range: $0.65 | 4.03% Avg Daily Range (30 D): $0.07 | 6.50% Avg Daily Range (90 D): $0.04 | 5.97% Institutional Daily Volume Avg Daily Volume: .04M Avg Daily Volume (30 D): .18M Avg Daily Volume (90 D): .09M Trade Size Avg Trade Size (Sh.): 7 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 42 Institutional Trades Total Inst.Trades: 896 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $1.26M Avg Inst. Trade (90 D): $1.26M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.56M Avg Closing Trade (30 D): $2.34M Avg Closing Trade (90 D): $2.34M Avg Closing Volume: 3.96K     News Nov 21, 2024 @ 9:47 PM BioXcel Therapeutics Announces Proposed Public Off... Source: Globe Newswire Nov 21, 2024 @ 9:47 PM BioXcel Therapeutics Announces Proposed Public Off... Source: N/A Jul 16, 2024 @ 11:02 AM BioXcel Therapeutics Announces Preliminary Estimat... Source: Bioxcel Therapeutics, Inc. Apr 24, 2024 @ 2:30 PM BioXcel Therapeutics Announces Late-Breaking Abstr... Source: BioXcel Therapeutics Mar 25, 2024 @ 11:00 AM BioXcel Therapeutics Announces $25 Million Registe... Source: BioXcel Therapeutics Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.04 $-.32 $-.21 Diluted EPS $-2.04 $-.32 $-.21 Revenue $ 2.28M $ .21M $ 1.1M Gross Profit $ .25M $ -.96M $ 1.04M Net Income / Loss $ -71M $ -13.65M $ -8.3M Operating Income / Loss $ -76.63M $ -15.29M $ -17.3M Cost of Revenue $ 2.03M $ 1.17M $ .06M Net Cash Flow $ -24.74M $ M $ M PE Ratio     Splits Feb 10, 2025:   16:1